Warning: The NCBI web site requires JavaScript to function. more...
Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent.
Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K, Seyfert C, van Valen F, Pap T, Meinecke I.
Arthritis Res Ther. 2009;11(1):R16. Epub 2009 Feb 5.
Related citations
Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.
Jüngel A, Baresova V, Ospelt C, Simmen BR, Michel BA, Gay RE, Gay S, Seemayer CA, Neidhart M.
Ann Rheum Dis. 2006 Jul;65(7):910-2. Epub 2005 Nov 10.
Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Park YW, Ji JD, Lee JS, Ryang DW, Yoo DH.
Scand J Rheumatol. 2003;32(6):356-63.
Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H, Nguyen N, Liu H, Eslick J, Esser S, Walsh K, Moore TL, Pope RM.
Arthritis Rheum. 2003 Nov;48(11):3096-101.
Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
Yang X, Wang J, Liu C, Grizzle WE, Yu S, Zhang S, Barnes S, Koopman WJ, Mountz JD, Kimberly RP, Zhang HG.
Am J Pathol. 2005 Sep;167(3):705-19.
Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA).
Wakisaka S, Suzuki N, Takeba Y, Shimoyama Y, Nagafuchi H, Takeno M, Saito N, Yokoe T, Kaneko A, Asai T, Sakane T.
Clin Exp Immunol. 1998 Oct;114(1):119-28.
Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells.
Nakamura C, Matsushita I, Kosaka E, Kondo T, Kimura T.
Rheumatology (Oxford). 2008 Apr;47(4):418-24. Epub 2008 Feb 15.
TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis.
Ichikawa K, Liu W, Fleck M, Zhang H, Zhao L, Ohtsuka T, Wang Z, Liu D, Mountz JD, Ohtsuki M, Koopman WJ, Kimberly R, Zhou T.
J Immunol. 2003 Jul 15;171(2):1061-9.
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.
Dharmapatni AA, Smith MD, Findlay DM, Holding CA, Evdokiou A, Ahern MJ, Weedon H, Chen P, Screaton G, Xu XN, Haynes DR.
Arthritis Res Ther. 2009;11(1):R13. Epub 2009 Jan 27.
Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-mediated signaling.
Sawamukai N, Yukawa S, Saito K, Nakayamada S, Kambayashi T, Tanaka Y.
Arthritis Rheum. 2010 Apr;62(4):952-9.
Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
Yao Q, Glorioso JC, Evans CH, Robbins PD, Kovesdi I, Oligino TJ, Ghivizzani SC.
J Gene Med. 2000 May-Jun;2(3):210-9.
RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.
Brentano F, Schorr O, Gay RE, Gay S, Kyburz D.
Arthritis Rheum. 2005 Sep;52(9):2656-65.
The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE, Gay S, Kyburz D.
Rheumatology (Oxford). 2007 Jul;46(7):1063-70. Epub 2007 Apr 10.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt.
Morel J, Audo R, Hahne M, Combe B.
J Biol Chem. 2005 Apr 22;280(16):15709-18. Epub 2005 Jan 31.
D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide.
Harada S, Sugiyama E, Taki H, Shinoda K, Fujita T, Maruyama M, Kobayashi M.
Clin Exp Rheumatol. 2002 Jul-Aug;20(4):469-76.
Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis.
Seemayer CA, Kuchen S, Kuenzler P, Rihosková V, Rethage J, Aicher WK, Michel BA, Gay RE, Kyburz D, Neidhart M, Gay S.
Am J Pathol. 2003 May;162(5):1549-57.
Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.
Miyashita T, Kawakami A, Nakashima T, Yamasaki S, Tamai M, Tanaka F, Kamachi M, Ida H, Migita K, Origuchi T, Nakao K, Eguchi K.
Clin Exp Immunol. 2004 Aug;137(2):430-6.
Intercellular adhesion molecule 1 underlies the functional heterogeneity of synovial cells in patients with rheumatoid arthritis: involvement of cell cycle machinery.
Tanaka Y, Nomi M, Fujii K, Hübscher S, Maruo A, Matsumoto S, Awazu Y, Saito K, Eto S, Minami Y.
Arthritis Rheum. 2000 Nov;43(11):2513-22.
Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M.
Arthritis Rheum. 2007 Apr;56(4):1067-75.
Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Yao Q, Wang S, Gambotto A, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ.
Gene Ther. 2003 Jun;10(12):1055-60.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on